Article Versions Notes

Christopoulos P, Dietz S, Kirchner M, Volckmar A-L, Endris V, Neumann O, Ogrodnik S, Heussel C-P, Herth FJ, Eichhorn M, et al. Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival. Cancers. 2019; 11(1):124. https://doi.org/10.3390/cancers11010124

Christopoulos, Petros, Steffen Dietz, Martina Kirchner, Anna-Lena Volckmar, Volker Endris, Olaf Neumann, Simon Ogrodnik, Claus-Peter Heussel, Felix J. Herth, Martin Eichhorn, and et al. 2019. "Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival" Cancers 11, no. 1: 124. https://doi.org/10.3390/cancers11010124

Christopoulos, P., Dietz, S., Kirchner, M., Volckmar, A.-L., Endris, V., Neumann, O., Ogrodnik, S., Heussel, C.-P., Herth, F. J., Eichhorn, M., Meister, M., Budczies, J., Allgäuer, M., Leichsenring, J., Zemojtel, T., Bischoff, H., Schirmacher, P., Thomas, M., Sültmann, H., & Stenzinger, A. (2019). Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival. Cancers, 11(1), 124. https://doi.org/10.3390/cancers11010124